MAIT cell activation augments adenovirus vector vaccine immunogenicity. (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/science.aax8819
PubMed Identifier: 33510029
Publication URI: http://europepmc.org/abstract/MED/33510029
Type: Journal Article/Review
Volume: 371
Parent Publication: Science (New York, N.Y.)
Issue: 6528
ISSN: 0036-8075